{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:40:29Z","timestamp":1787330429240,"version":"build-2736575974"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s40266-021-00879-x","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T09:02:41Z","timestamp":1625734961000},"page":"735-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Fibromyalgia in Older Individuals"],"prefix":"10.1007","volume":"38","author":[{"given":"Amir","family":"Minerbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-3175","authenticated-orcid":false,"given":"Mary-Ann","family":"Fitzcharles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"issue":"15","key":"879_CR1","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547\u201355.","journal-title":"JAMA"},{"issue":"6","key":"879_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jpain.2018.10.008","volume":"20","author":"LM Arnold","year":"2019","unstructured":"Arnold LM, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20(6):611\u201328.","journal-title":"J Pain"},{"issue":"9","key":"879_CR3","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/ejp.1252","volume":"22","author":"MA Fitzcharles","year":"2018","unstructured":"Fitzcharles MA, Perrot S, Hauser W. Comorbid fibromyalgia: a qualitative review of prevalence and importance. Eur J Pain. 2018;22(9):1565\u201376.","journal-title":"Eur J Pain"},{"issue":"8","key":"879_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","volume":"17","author":"LP Queiroz","year":"2013","unstructured":"Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356\u201362.","journal-title":"Curr Pain Headache Rep"},{"issue":"12","key":"879_CR5","first-page":"41","volume":"99","author":"JC Defillo-Draiby","year":"2016","unstructured":"Defillo-Draiby JC, Page JS. Fibromyalgia syndrome, a geriatric challenge. R I Med J (2013). 2016;99(12):41\u20134.","journal-title":"R I Med J (2013)."},{"issue":"1","key":"879_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/art.1780380104","volume":"38","author":"F Wolfe","year":"1995","unstructured":"Wolfe F, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19\u201328.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"879_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138024","volume":"10","author":"B Walitt","year":"2015","unstructured":"Walitt B, et al. The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PLoS ONE. 2015;10(9): e0138024.","journal-title":"PLoS ONE"},{"issue":"11","key":"879_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1532-5415.1988.tb04364.x","volume":"36","author":"MB Yunus","year":"1988","unstructured":"Yunus MB, et al. Fibromyalgia syndrome among the elderly. Comparison with younger patients. J Am Geriatr Soc. 1988;36(11):987\u201395.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"879_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/NNR.0b013e318273b853","volume":"62","author":"LM Torma","year":"2013","unstructured":"Torma LM, et al. Growing old with fibromyalgia: factors that predict physical function. Nurs Res. 2013;62(1):16\u201324.","journal-title":"Nurs Res"},{"issue":"5","key":"879_CR10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/BF03654827","volume":"24","author":"S Pautex","year":"2012","unstructured":"Pautex S, Cedraschi C, Allaz AF. Characteristics of elderly patients with fibromyalgia: a pilot retrospective study. Aging Clin Exp Res. 2012;24(5):490\u20134.","journal-title":"Aging Clin Exp Res"},{"issue":"9","key":"879_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137137","volume":"10","author":"CH Su","year":"2015","unstructured":"Su CH, et al. Increased risk of coronary heart disease in patients with primary fibromyalgia and those with concomitant comorbidity: a Taiwanese population-based cohort study. PLoS ONE. 2015;10(9): e0137137.","journal-title":"PLoS ONE"},{"issue":"2","key":"879_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.amjms.2017.09.002","volume":"355","author":"NS Tzeng","year":"2018","unstructured":"Tzeng NS, et al. Fibromyalgia and risk of dementia-a nationwide, population-based cohort study. Am J Med Sci. 2018;355(2):153\u201361.","journal-title":"Am J Med Sci"},{"issue":"12","key":"879_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225836","volume":"14","author":"M L\u00f3pez-Ruiz","year":"2019","unstructured":"L\u00f3pez-Ruiz M, et al. Central sensitization in knee osteoarthritis and fibromyalgia: beyond depression and anxiety. PLoS ONE. 2019;14(12): e0225836.","journal-title":"PLoS ONE"},{"key":"879_CR14","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","volume":"397","author":"M Fitzcharles","year":"2021","unstructured":"Fitzcharles M, Cohen SP, Clauw D, Littlejohn G, Usui C, Hauser W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397:2098\u2013110.","journal-title":"Lancet"},{"issue":"7","key":"879_CR15","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","volume":"157","author":"E Kosek","year":"2016","unstructured":"Kosek E, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382\u20136.","journal-title":"Pain"},{"issue":"1","key":"879_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/j.pain.0000000000001390","volume":"160","author":"M Nicholas","year":"2019","unstructured":"Nicholas M, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160(1):28\u201337.","journal-title":"Pain"},{"issue":"11","key":"879_CR17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol. 2010;63(11):1179\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"879_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, et al. 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319\u201329.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"879_CR19","first-page":"613","volume":"50","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, et al. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613\u201321.","journal-title":"Psychosomatics"},{"issue":"3","key":"879_CR20","doi-asserted-by":"publisher","first-page":"e598","DOI":"10.1097\/PR9.0000000000000598","volume":"2","author":"W H\u00e4user","year":"2017","unstructured":"H\u00e4user W, Perrot S, Sommer C, Shir Y, Fitzcharles M. Diagnostic confounders of chronic widespread pain: not always fibromyalgia. Pain Rep. 2017;2(3):e598.","journal-title":"Pain Rep."},{"issue":"8","key":"879_CR21","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3899\/jrheum.130127","volume":"40","author":"MA Fitzcharles","year":"2013","unstructured":"Fitzcharles MA, et al. Canadian Pain Society and Canadian Rheumatology Association recommendations for rational care of persons with fibromyalgia. A summary report. J Rheumatol. 2013;40(8):1388\u201393.","journal-title":"J Rheumatol"},{"issue":"12","key":"879_CR22","first-page":"742","volume":"152","author":"JN Ablin","year":"2013","unstructured":"Ablin JN, et al. Guidelines for the diagnosis and treatment of the fibromyalgia syndrome. Harefuah. 2013;152(12):742\u201351 (In Hebrew).","journal-title":"Harefuah"},{"issue":"3","key":"879_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00482-012-1169-x","volume":"26","author":"W Eich","year":"2012","unstructured":"Eich W, et al. Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis. Schmerz. 2012;26(3):247\u201358 (In German).","journal-title":"Schmerz"},{"issue":"2","key":"879_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","volume":"76","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane GJ, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318\u201328.","journal-title":"Ann Rheum Dis"},{"issue":"12 Suppl","key":"879_CR25","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.amjmed.2009.09.007","volume":"122","author":"DL Goldenberg","year":"2009","unstructured":"Goldenberg DL. Diagnosis and differential diagnosis of fibromyalgia. Am J Med. 2009;122(12 Suppl):S14\u201321.","journal-title":"Am J Med"},{"key":"879_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/B978-0-7020-4086-3.00035-7","volume":"119","author":"JL Melancia","year":"2014","unstructured":"Melancia JL, Francisco AF, Antunes JL. Spinal stenosis. Handb Clin Neurol. 2014;119:541\u20139.","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"879_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1517\/14740338.2011.540568","volume":"10","author":"TT Abd","year":"2011","unstructured":"Abd TT, Jacobson TA. Statin-induced myopathy: a review and update. Expert Opin Drug Saf. 2011;10(3):373\u201387.","journal-title":"Expert Opin Drug Saf"},{"issue":"18","key":"879_CR28","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1002\/cncr.25385","volume":"116","author":"NL Henry","year":"2010","unstructured":"Henry NL, et al. A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography. Cancer. 2010;116(18):4360\u20137.","journal-title":"Cancer"},{"issue":"2","key":"879_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14310\/horm.2002.1226","volume":"8","author":"PD Papapetrou","year":"2009","unstructured":"Papapetrou PD. Bisphosphonate-associated adverse events. Hormones (Athens). 2009;8(2):96\u2013110.","journal-title":"Hormones (Athens)"},{"issue":"11","key":"879_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","volume":"16","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, et al. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020;16(11):645\u201360.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"879_CR31","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1097\/j.pain.0000000000000285","volume":"156","author":"K Doppler","year":"2015","unstructured":"Doppler K, et al. Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain. 2015;156(11):2319\u201325.","journal-title":"Pain"},{"issue":"15","key":"879_CR32","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/WNL.0b013e3182a8236e","volume":"81","author":"MJ Peters","year":"2013","unstructured":"Peters MJ, et al. Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology. 2013;81(15):1356\u201360.","journal-title":"Neurology"},{"issue":"20","key":"879_CR33","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.3390\/ijms20205164","volume":"20","author":"VA Ryabkova","year":"2019","unstructured":"Ryabkova VA, Churilov LP, Shoenfeld Y. Neuroimmunology: what role for autoimmunity, neuroinflammation, and small fiber neuropathy in fibromyalgia, chronic fatigue syndrome, and adverse events after human papillomavirus vaccination? Int J Mol Sci. 2019;20(20):5164.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"879_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/j.pain.0000000000000769","volume":"158","author":"KM Naugle","year":"2017","unstructured":"Naugle KM, et al. Physical activity behavior predicts endogenous pain modulation in older adults. Pain. 2017;158(3):383\u201390.","journal-title":"Pain"},{"key":"879_CR35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ebiom.2019.07.031","volume":"46","author":"M Clos-Garcia","year":"2019","unstructured":"Clos-Garcia M, et al. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine. 2019;46:499\u2013511.","journal-title":"EBioMedicine"},{"issue":"2","key":"879_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s42255-021-00348-0","volume":"3","author":"T Wilmanski","year":"2021","unstructured":"Wilmanski T, et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat Metab. 2021;3(2):274\u201386.","journal-title":"Nat Metab"},{"key":"879_CR37","doi-asserted-by":"crossref","unstructured":"Freidin MB et al. An association between chronic widespread pain and the gut microbiome. Rheumatology (Oxford) (Epub 17 Dec 2020)","DOI":"10.1093\/rheumatology\/keaa847"},{"issue":"Suppl 123","key":"879_CR38","first-page":"99","volume":"38","author":"A Minerbi","year":"2020","unstructured":"Minerbi A, Fitzcharles MA. Gut microbiome: pertinence in fibromyalgia. Clin Exp Rheumatol. 2020;38(Suppl 123):99\u2013104.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"879_CR39","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1097\/j.pain.0000000000001640","volume":"160","author":"A Minerbi","year":"2019","unstructured":"Minerbi A, et al. Altered microbiome composition in individuals with fibromyalgia. Pain. 2019;160(11):2589\u2013602.","journal-title":"Pain"},{"key":"879_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/485272","volume":"2013","author":"J Ablin","year":"2013","unstructured":"Ablin J, et al. Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Alternat Med. 2013;2013: 485272.","journal-title":"Evid Based Complement Alternat Med."},{"issue":"3","key":"879_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1155\/2013\/918216","volume":"18","author":"MA Fitzcharles","year":"2013","unstructured":"Fitzcharles MA, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013;18(3):119\u201326.","journal-title":"Pain Res Manag"},{"issue":"3","key":"879_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00482-017-0201-6","volume":"31","author":"F Petzke","year":"2017","unstructured":"Petzke F, et al. General treatment principles, coordination of care and patient education in fibromyalgia syndrome: updated guidelines 2017 and overview of systematic review articles. Schmerz. 2017;31(3):246\u201354 (In German).","journal-title":"Schmerz"},{"issue":"2","key":"879_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF02908299","volume":"21","author":"LA Rossy","year":"1999","unstructured":"Rossy LA, et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med. 1999;21(2):180\u201391.","journal-title":"Ann Behav Med"},{"issue":"6","key":"879_CR44","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s10865-015-9647-0","volume":"38","author":"D Cosio","year":"2015","unstructured":"Cosio D, Schafer T. Implementing an acceptance and commitment therapy group protocol with veterans using VA\u2019s stepped care model of pain management. J Behav Med. 2015;38(6):984\u201397.","journal-title":"J Behav Med"},{"key":"879_CR45","doi-asserted-by":"publisher","first-page":"l2323","DOI":"10.1136\/bmj.l2323","volume":"365","author":"A Mok","year":"2019","unstructured":"Mok A, et al. Physical activity trajectories and mortality: population based cohort study. BMJ. 2019;365:l2323.","journal-title":"BMJ"},{"issue":"3","key":"879_CR46","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jamainternmed.2018.5406","volume":"179","author":"BP de Souto","year":"2019","unstructured":"de Souto BP, et al. Association of long-term exercise training with risk of falls, fractures, hospitalizations, and mortality in older adults: a systematic review and meta-analysis. JAMA Intern Med. 2019;179(3):394\u2013405.","journal-title":"JAMA Intern Med"},{"issue":"1\u20133","key":"879_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pain.2009.07.019","volume":"147","author":"PA Karsdorp","year":"2009","unstructured":"Karsdorp PA, Vlaeyen JW. Active avoidance but not activity pacing is associated with disability in fibromyalgia. Pain. 2009;147(1\u20133):29\u201335.","journal-title":"Pain"},{"issue":"2","key":"879_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.genhosppsych.2008.12.001","volume":"31","author":"X Torres","year":"2009","unstructured":"Torres X, et al. Pain locus of control predicts return to work among Spanish fibromyalgia patients after completion of a multidisciplinary pain program. Gen Hosp Psychiatry. 2009;31(2):137\u201345.","journal-title":"Gen Hosp Psychiatry"},{"key":"879_CR49","first-page":"463","volume":"5","author":"K Malin","year":"2012","unstructured":"Malin K, Littlejohn GO. Psychological control is a key modulator of fibromyalgia symptoms and comorbidities. J Pain Res. 2012;5:463\u201371.","journal-title":"J Pain Res"},{"issue":"2","key":"879_CR50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.23736\/S1973-9087.19.05524-2","volume":"55","author":"MC Garc\u00eda-R\u00edos","year":"2019","unstructured":"Garc\u00eda-R\u00edos MC, et al. Effectiveness of health education in patients with fibromyalgia: a systematic review. Eur J Phys Rehabil Med. 2019;55(2):301\u201313.","journal-title":"Eur J Phys Rehabil Med"},{"issue":"5","key":"879_CR51","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11916-011-0214-2","volume":"15","author":"AJ Busch","year":"2011","unstructured":"Busch AJ, et al. Exercise therapy for fibromyalgia. Curr Pain Headache Rep. 2011;15(5):358\u201367.","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"879_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jpain.2011.11.001","volume":"13","author":"LD Ellingson","year":"2012","unstructured":"Ellingson LD, et al. Physical activity, sustained sedentary behavior, and pain modulation in women with fibromyalgia. J Pain. 2012;13(2):195\u2013206.","journal-title":"J Pain"},{"issue":"11","key":"879_CR53","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/acr.22610","volume":"67","author":"A Soriano-Maldonado","year":"2015","unstructured":"Soriano-Maldonado A, et al. Association of physical fitness with pain in women with fibromyalgia: the Al-\u00c1ndalus project. Arthritis Care Res (Hoboken). 2015;67(11):1561\u201370.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"2","key":"879_CR54","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/sms.13318","volume":"29","author":"M Borges-Cosic","year":"2019","unstructured":"Borges-Cosic M, et al. Sedentary time, physical activity, and sleep quality in fibromyalgia: the Al-\u00c1ndalus project. Scand J Med Sci Sports. 2019;29(2):266\u201374.","journal-title":"Scand J Med Sci Sports"},{"issue":"3","key":"879_CR55","doi-asserted-by":"publisher","DOI":"10.2196\/14538","volume":"8","author":"B Gavil\u00e1n-Carrera","year":"2020","unstructured":"Gavil\u00e1n-Carrera B, et al. Patterns of sedentary time and quality of life in women with fibromyalgia: cross-sectional study from the Al-\u00c1ndalus project. JMIR Mhealth Uhealth. 2020;8(3): e14538.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"3","key":"879_CR56","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jshs.2018.07.001","volume":"8","author":"B Gavil\u00e1n-Carrera","year":"2019","unstructured":"Gavil\u00e1n-Carrera B, et al. Association of objectively measured physical activity and sedentary time with health-related quality of life in women with fibromyalgia: the Al-\u00c1ndalus project. J Sport Health Sci. 2019;8(3):258\u201366.","journal-title":"J Sport Health Sci"},{"issue":"6","key":"879_CR57","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.semarthrit.2020.02.003","volume":"50","author":"A Andrade","year":"2020","unstructured":"Andrade A, Dominski FH, Sieczkowska SM. What we already know about the effects of exercise in patients with fibromyalgia: an umbrella review. Semin Arthritis Rheum. 2020;50(6):1465\u201380.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"879_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/PHM.0000000000001093","volume":"98","author":"A Winkelmann","year":"2019","unstructured":"Winkelmann A. Is aerobic exercise training beneficial for adults with fibromyalgia? A cochrane review summary with commentary. Am J Phys Med Rehabil. 2019;98(2):169\u201370.","journal-title":"Am J Phys Med Rehabil"},{"issue":"4","key":"879_CR59","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.apmr.2020.06.019","volume":"102","author":"F Est\u00e9vez-L\u00f3pez","year":"2020","unstructured":"Est\u00e9vez-L\u00f3pez F, et al. Effectiveness of exercise on fatigue and sleep quality in fibromyalgia: a systematic review and meta-analysis of randomized trials. Arch Phys Med Rehabil. 2020;102(4):752\u201361.","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"879_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ejp.1666","volume":"25","author":"KFM Franco","year":"2021","unstructured":"Franco KFM, et al. Prescription of exercises for the treatment of chronic pain along the continuum of nociplastic pain: a systematic review with meta-analysis. Eur J Pain. 2021;25(1):51\u201370.","journal-title":"Eur J Pain"},{"issue":"8","key":"879_CR61","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.apmr.2016.01.026","volume":"97","author":"G Fernandes","year":"2016","unstructured":"Fernandes G, et al. Swimming improves pain and functional capacity of patients with fibromyalgia: a randomized controlled trial. Arch Phys Med Rehabil. 2016;97(8):1269\u201375.","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"879_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1300\/J094v03n03_04","volume":"3","author":"FTJ Verstappen","year":"1995","unstructured":"Verstappen FTJ, et al. Fitness characteristics of female patients with fibromyalgia. J Musculoskelet Pain. 1995;3(3):45\u201358.","journal-title":"J Musculoskelet Pain."},{"issue":"12","key":"879_CR63","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/acr.22398","volume":"66","author":"AS Kaleth","year":"2014","unstructured":"Kaleth AS, Slaven JE, Ang DC. Does increasing steps per day predict improvement in physical function and pain interference in adults with fibromyalgia? Arthritis Care Res (Hoboken). 2014;66(12):1887\u201394.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"879_CR64","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001684","author":"AS Kaleth","year":"2020","unstructured":"Kaleth AS, et al. Predictors of physical activity in patients with fibromyalgia: a path analysis. J Clin Rheumatol. 2020. https:\/\/doi.org\/10.1097\/RHU.0000000000001684.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"879_CR65","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.semarthrit.2021.02.007","volume":"51","author":"M D'Onghia","year":"2021","unstructured":"D\u2019Onghia M, et al. Fibromyalgia and obesity: a comprehensive systematic review and meta-analysis. Semin Arthritis Rheum. 2021;51(2):409\u201324.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"879_CR66","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.3390\/jcm9124000","volume":"9","author":"C Climent-Sanz","year":"2020","unstructured":"Climent-Sanz C, et al. poor sleep quality experience and self-management strategies in fibromyalgia: a qualitative metasynthesis. J Clin Med. 2020;9(12):4000.","journal-title":"J Clin Med"},{"issue":"11","key":"879_CR67","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.5665\/sleep.5158","volume":"38","author":"NK Tang","year":"2015","unstructured":"Tang NK, et al. Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta-analysis of patient-reported outcomes in randomized controlled trials. Sleep. 2015;38(11):1751\u201364.","journal-title":"Sleep"},{"issue":"3","key":"879_CR68","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/AJP.0000000000000401","volume":"33","author":"D Antcliff","year":"2017","unstructured":"Antcliff D, et al. Activity pacing is associated with better and worse symptoms for patients with long-term conditions. Clin J Pain. 2017;33(3):205\u201314.","journal-title":"Clin J Pain"},{"issue":"9","key":"879_CR69","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.endinu.2017.07.002","volume":"64","author":"MM L\u00f3pez-Rodr\u00edguez","year":"2017","unstructured":"L\u00f3pez-Rodr\u00edguez MM, et al. Patterns of food avoidance and eating behavior in women with fibromyalgia. Endocrinol Diabetes Nutr. 2017;64(9):480\u201390.","journal-title":"Endocrinol Diabetes Nutr."},{"issue":"Suppl 1","key":"879_CR70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/07853890.2018.1564360","volume":"51","author":"AR Silva","year":"2019","unstructured":"Silva AR, et al. Dietary interventions in fibromyalgia: a systematic review. Ann Med. 2019;51(Suppl 1):2\u201314.","journal-title":"Ann Med"},{"issue":"5","key":"879_CR71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11916-018-0688-2","volume":"22","author":"MM Aman","year":"2018","unstructured":"Aman MM, et al. Evidence-based non-pharmacological therapies for fibromyalgia. Curr Pain Headache Rep. 2018;22(5):33.","journal-title":"Curr Pain Headache Rep"},{"issue":"9","key":"879_CR72","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3390\/nu12092525","volume":"12","author":"G Pagliai","year":"2020","unstructured":"Pagliai G, et al. Nutritional interventions in the management of fibromyalgia syndrome. Nutrients. 2020;12(9):2525.","journal-title":"Nutrients"},{"issue":"6","key":"879_CR73","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/MCG.0000000000000651","volume":"51","author":"M Slim","year":"2017","unstructured":"Slim M, et al. The effects of a gluten-free diet versus a hypocaloric diet among patients with fibromyalgia experiencing gluten sensitivity-like symptoms: a pilot, open-label randomized clinical trial. J Clin Gastroenterol. 2017;51(6):500\u20137.","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"879_CR74","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00296-013-2801-5","volume":"34","author":"MY Vellisca","year":"2014","unstructured":"Vellisca MY, Lator JI. Monosodium glutamate and aspartame in perceived pain in fibromyalgia. Rheumatol Int. 2014;34(7):1011\u20133.","journal-title":"Rheumatol Int"},{"issue":"7","key":"879_CR75","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3390\/ijerph17072227","volume":"17","author":"A Mart\u00ednez-Rodr\u00edguez","year":"2020","unstructured":"Mart\u00ednez-Rodr\u00edguez A, et al. Psychological and sleep effects of tryptophan and magnesium-enriched Mediterranean diet in women with fibromyalgia. Int J Environ Res Public Health. 2020;17(7):2227.","journal-title":"Int J Environ Res Public Health"},{"key":"879_CR76","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.sjpain.2016.07.004","volume":"13","author":"AP Marum","year":"2016","unstructured":"Marum AP, et al. A low fermentable oligo-di-mono saccharides and polyols (FODMAP) diet reduced pain and improved daily life in fibromyalgia patients. Scand J Pain. 2016;13:166\u201372.","journal-title":"Scand J Pain"},{"issue":"9","key":"879_CR77","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.3390\/nu12092664","volume":"12","author":"E Lowry","year":"2020","unstructured":"Lowry E, et al. Dietary interventions in the management of fibromyalgia: a systematic review and best-evidence synthesis. Nutrients. 2020;12(9):2664.","journal-title":"Nutrients"},{"issue":"3","key":"879_CR78","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3390\/jcm9030702","volume":"9","author":"\u00d6 Elma","year":"2020","unstructured":"Elma \u00d6, et al. Do nutritional factors interact with chronic musculoskeletal pain? A systematic review. J Clin Med. 2020;9(3):702.","journal-title":"J Clin Med"},{"issue":"9","key":"879_CR79","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1007\/s00296-011-2010-z","volume":"32","author":"LI Arranz","year":"2012","unstructured":"Arranz LI, Canela M, Rafecas M. Dietary aspects in fibromyalgia patients: results of a survey on food awareness, allergies, and nutritional supplementation. Rheumatol Int. 2012;32(9):2615\u201321.","journal-title":"Rheumatol Int"},{"issue":"2","key":"879_CR80","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ejp.1121","volume":"22","author":"K Bernardy","year":"2018","unstructured":"Bernardy K, et al. Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials. Eur J Pain. 2018;22(2):242\u201360.","journal-title":"Eur J Pain"},{"issue":"12","key":"879_CR81","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1097\/j.pain.0000000000001036","volume":"158","author":"MA Lumley","year":"2017","unstructured":"Lumley MA, et al. Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial. Pain. 2017;158(12):2354\u201363.","journal-title":"Pain"},{"issue":"9","key":"879_CR82","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/rheumatology\/kep182","volume":"48","author":"J Langhorst","year":"2009","unstructured":"Langhorst J, et al. Efficacy of hydrotherapy in fibromyalgia syndrome\u2014a meta-analysis of randomized controlled clinical trials. Rheumatology (Oxford). 2009;48(9):1155\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"879_CR83","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00296-008-0674-9","volume":"29","author":"JG McVeigh","year":"2008","unstructured":"McVeigh JG, et al. The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review. Rheumatol Int. 2008;29(2):119\u201330.","journal-title":"Rheumatol Int"},{"issue":"1","key":"879_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00296-009-0977-5","volume":"30","author":"J Baranowsky","year":"2009","unstructured":"Baranowsky J, et al. Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia. Rheumatol Int. 2009;30(1):1\u201321.","journal-title":"Rheumatol Int"},{"key":"879_CR85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/JPR.S8052","volume":"2","author":"L Perraton","year":"2009","unstructured":"Perraton L, Machotka Z, Kumar S. Components of effective randomized controlled trials of hydrotherapy programs for fibromyalgia syndrome: a systematic review. J Pain Res. 2009;2:165\u201373.","journal-title":"J Pain Res"},{"issue":"10","key":"879_CR86","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s10067-009-1217-9","volume":"28","author":"E Ernst","year":"2009","unstructured":"Ernst E. Chiropractic treatment for fibromyalgia: a systematic review. Clin Rheumatol. 2009;28(10):1175\u20138.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"879_CR87","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jmpt.2008.08.012","volume":"32","author":"M Schneider","year":"2009","unstructured":"Schneider M, et al. Chiropractic management of fibromyalgia syndrome: a systematic review of the literature. J Manip Physiol Ther. 2009;32(1):25\u201340.","journal-title":"J Manip Physiol Ther"},{"issue":"1","key":"879_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/art.1790090105","volume":"9","author":"M Pioro-Boisset","year":"1996","unstructured":"Pioro-Boisset M, Esdaile JM, Fitzcharles MA. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res. 1996;9(1):13\u20137.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"879_CR89","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1089\/acm.2009.0599","volume":"16","author":"H Cao","year":"2010","unstructured":"Cao H, Liu J, Lewith GT. Traditional Chinese medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med. 2010;16(4):397\u2013409.","journal-title":"J Altern Complement Med"},{"issue":"6","key":"879_CR90","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/rheumatology\/keq025","volume":"49","author":"V De Silva","year":"2010","unstructured":"De Silva V, et al. Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review. Rheumatology (Oxford). 2010;49(6):1063\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"879_CR91","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/1874312900903010025","volume":"3","author":"E Martin-Sanchez","year":"2009","unstructured":"Martin-Sanchez E, et al. Efficacy of acupuncture for the treatment of fibromyalgia: systematic review and meta-analysis of randomized trials. Open Rheumatol J. 2009;3:25\u20139.","journal-title":"Open Rheumatol J."},{"issue":"5","key":"879_CR92","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/rheumatology\/kel406","volume":"46","author":"E Mayhew","year":"2007","unstructured":"Mayhew E, Ernst E. Acupuncture for fibromyalgia\u2014a systematic review of randomized clinical trials. Rheumatology (Oxford). 2007;46(5):801\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"879_CR93","first-page":"213","volume":"48","author":"BM Berman","year":"1999","unstructured":"Berman BM, et al. Is acupuncture effective in the treatment of fibromyalgia? J Fam Pract. 1999;48(3):213\u20138.","journal-title":"J Fam Pract"},{"issue":"4","key":"879_CR94","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/rheumatology\/kep439","volume":"49","author":"J Langhorst","year":"2010","unstructured":"Langhorst J, et al. Efficacy of acupuncture in fibromyalgia syndrome\u2014a systematic review with a meta-analysis of controlled clinical trials. Rheumatology. 2010;49(4):778\u201388.","journal-title":"Rheumatology"},{"issue":"5","key":"879_CR95","first-page":"CD007070","volume":"2013","author":"JC Deare","year":"2013","unstructured":"Deare JC, et al. Acupuncture for treating fibromyalgia. Cochrane Database Syst Rev. 2013;2013(5):CD007070.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"879_CR96","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10067-009-1361-2","volume":"29","author":"R Perry","year":"2010","unstructured":"Perry R, Terry R, Ernst E. A systematic review of homoeopathy for the treatment of fibromyalgia. Clin Rheumatol. 2010;29(5):457\u201364.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"879_CR97","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2174\/092986710790416326","volume":"17","author":"A Corsonello","year":"2010","unstructured":"Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17(6):571\u201384.","journal-title":"Curr Med Chem"},{"issue":"1","key":"879_CR98","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.mayocp.2020.06.012","volume":"96","author":"RW Hoel","year":"2021","unstructured":"Hoel RW, Connolly RMG, Takahashi PY. Polypharmacy management in older patients. Mayo Clin Proc. 2021;96(1):242\u201356.","journal-title":"Mayo Clin Proc"},{"key":"879_CR99","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society 2019 updated AGS beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u2013694","DOI":"10.1111\/jgs.15767"},{"issue":"4","key":"879_CR100","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrrheum.2009.25","volume":"5","author":"CS Boomershine","year":"2009","unstructured":"Boomershine CS, Crofford LJ. A symptom-based approach to pharmacologic management of fibromyalgia. Nat Rev Rheumatol. 2009;5(4):191\u20139.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"879_CR101","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1533-2500.2008.00190.x","volume":"8","author":"S Perrot","year":"2008","unstructured":"Perrot S, Dickenson AH, Bennett RM. Fibromyalgia: harmonizing science with clinical practice considerations. Pain Pract. 2008;8(3):177\u201389.","journal-title":"Pain Pract"},{"issue":"2","key":"879_CR102","first-page":"CD010585","volume":"2","author":"J Thorpe","year":"2018","unstructured":"Thorpe J, et al. Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database Syst Rev. 2018;2(2):CD010585.","journal-title":"Cochrane Database Syst Rev"},{"key":"879_CR103","unstructured":"World Health Organization. WHO Pain Ladder. 1986. http:\/\/www.who.int\/cancer\/palliative\/painladder\/en\/. Accessed 22 Nov 2011"},{"issue":"7","key":"879_CR104","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","volume":"114","author":"RM Bennett","year":"2003","unstructured":"Bennett RM, et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003;114(7):537\u201345.","journal-title":"Am J Med"},{"key":"879_CR105","doi-asserted-by":"crossref","unstructured":"What dose of paracetamol for older people? Drug Ther Bull. 2018;56(6):69\u201372","DOI":"10.1136\/dtb.2018.6.0636"},{"issue":"3\u20134","key":"879_CR106","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1527-3458.2006.00250.x","volume":"12","author":"A Bertolini","year":"2006","unstructured":"Bertolini A, et al. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006;12(3\u20134):250\u201375.","journal-title":"CNS Drug Rev"},{"issue":"Suppl 1","key":"879_CR107","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40266-019-00658-9","volume":"36","author":"PG Conaghan","year":"2019","unstructured":"Conaghan PG, et al. Safety of paracetamol in osteoarthritis: what does the literature say? Drugs Aging. 2019;36(Suppl 1):7\u201314.","journal-title":"Drugs Aging"},{"issue":"1","key":"879_CR108","doi-asserted-by":"publisher","first-page":"38","DOI":"10.14219\/jada.archive.2011.0026","volume":"142","author":"J Guggenheimer","year":"2011","unstructured":"Guggenheimer J, Moore PA. The therapeutic applications of and risks associated with acetaminophen use: a review and update. J Am Dent Assoc. 2011;142(1):38\u201344.","journal-title":"J Am Dent Assoc"},{"issue":"1","key":"879_CR109","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2006\/642568","volume":"11","author":"ME Lynch","year":"2006","unstructured":"Lynch ME, Watson CP. The pharmacotherapy of chronic pain: a review. Pain Res Manag. 2006;11(1):11\u201338.","journal-title":"Pain Res Manag"},{"issue":"2","key":"879_CR110","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2","volume":"43","author":"F Wolfe","year":"2000","unstructured":"Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum. 2000;43(2):378\u201385.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"879_CR111","first-page":"CD012332","volume":"3","author":"S Derry","year":"2017","unstructured":"Derry S, et al. Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults. Cochrane Database Syst Rev. 2017;3(3):CD012332.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"879_CR112","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","volume":"6","author":"GJ Sills","year":"2006","unstructured":"Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006;6(1):108\u201313.","journal-title":"Curr Opin Pharmacol"},{"issue":"1\u20132","key":"879_CR113","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","volume":"145","author":"W Hauser","year":"2009","unstructured":"Hauser W, et al. Treatment of fibromyalgia syndrome with gabapentin and pregabalin\u2014a meta-analysis of randomized controlled trials. Pain. 2009;145(1\u20132):69\u201381.","journal-title":"Pain"},{"issue":"4","key":"879_CR114","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jpain.2010.09.007","volume":"12","author":"AC Siler","year":"2011","unstructured":"Siler AC, et al. Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia. J Pain. 2011;12(4):407\u201315.","journal-title":"J Pain"},{"issue":"10","key":"879_CR115","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4045\/tidsskr.09.0576","volume":"130","author":"R Holtedahl","year":"2010","unstructured":"Holtedahl R. Questionable documentation of the effect of pregabalin in fibromyalgia. Tidsskr Nor Laegeforen. 2010;130(10):1032\u20136 (In Norwegian).","journal-title":"Tidsskr Nor Laegeforen"},{"key":"879_CR116","doi-asserted-by":"crossref","unstructured":"Moore RA et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;(3):CD007076.","DOI":"10.1002\/14651858.CD007076.pub2"},{"issue":"9","key":"879_CR117","first-page":"CD011790","volume":"9","author":"S Derry","year":"2016","unstructured":"Derry S, et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016;9(9):CD011790.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"879_CR118","first-page":"CD012188","volume":"1","author":"TE Cooper","year":"2017","unstructured":"Cooper TE, et al. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. 2017;1(1):CD012188.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"879_CR119","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/0091270003251119","volume":"43","author":"EJ Randinitis","year":"2003","unstructured":"Randinitis EJ, et al. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol. 2003;43(3):277\u201383.","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"879_CR120","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s40264-018-0695-6","volume":"41","author":"LO de Landaluce","year":"2018","unstructured":"de Landaluce LO, et al. Gabapentin and pregabalin and risk of atrial fibrillation in the elderly: a population-based cohort study in an electronic prescription database. Drug Saf. 2018;41(12):1325\u201331.","journal-title":"Drug Saf"},{"issue":"2","key":"879_CR121","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1001\/jama.2008.944","volume":"301","author":"W Hauser","year":"2009","unstructured":"Hauser W, et al. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA. 2009;301(2):198\u2013209.","journal-title":"JAMA"},{"key":"879_CR122","doi-asserted-by":"crossref","unstructured":"Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev. 2009;(4):CD007115","DOI":"10.1002\/14651858.CD007115.pub2"},{"issue":"9","key":"879_CR123","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s10067-009-1203-2","volume":"28","author":"EHS Choy","year":"2009","unstructured":"Choy EHS, et al. Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials. Clin Rheumatol. 2009;28(9):1035\u201344.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"879_CR124","first-page":"CD010292","volume":"2","author":"P Welsch","year":"2018","unstructured":"Welsch P, et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev. 2018;2(2):CD010292.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"879_CR125","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/j.pain.0000000000000558","volume":"157","author":"I Gilron","year":"2016","unstructured":"Gilron I, et al. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016;157(7):1532\u201340.","journal-title":"Pain"},{"issue":"19","key":"879_CR126","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1001\/jama.292.19.2388","volume":"292","author":"DL Goldenberg","year":"2004","unstructured":"Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292(19):2388\u201395.","journal-title":"JAMA"},{"issue":"1","key":"879_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jcpt.12216","volume":"40","author":"LA VanderWeide","year":"2015","unstructured":"VanderWeide LA, Smith SM, Trinkley KE. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia. J Clin Pharm Ther. 2015;40(1):1\u20136.","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"879_CR128","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/ageing\/afs072","volume":"41","author":"S Abou-Raya","year":"2012","unstructured":"Abou-Raya S, Abou-Raya A, Helmii M. Duloxetine for the management of pain in older adults with knee osteoarthritis: randomised placebo-controlled trial. Age Ageing. 2012;41(5):646\u201352.","journal-title":"Age Ageing"},{"issue":"2","key":"879_CR129","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1176\/appi.psy.41.2.104","volume":"41","author":"LM Arnold","year":"2000","unstructured":"Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics. 2000;41(2):104\u201313.","journal-title":"Psychosomatics"},{"issue":"12","key":"879_CR130","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1093\/rheumatology\/ken317","volume":"47","author":"B Nishishinya","year":"2008","unstructured":"Nishishinya B, et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology. 2008;47(12):1741\u20136.","journal-title":"Rheumatology"},{"issue":"10","key":"879_CR131","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1586\/14737175.2015.1091726","volume":"15","author":"F Rico-Villademoros","year":"2015","unstructured":"Rico-Villademoros F, Slim M, Calandre EP. Amitriptyline for the treatment of fibromyalgia: a comprehensive review. Expert Rev Neurother. 2015;15(10):1123\u201350.","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"879_CR132","first-page":"CD012708","volume":"8","author":"P Welsch","year":"2018","unstructured":"Welsch P, et al. Mirtazapine for fibromyalgia in adults. Cochrane Database Syst Rev. 2018;8(8):CD012708.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"879_CR133","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/art.20076","volume":"51","author":"JK Tofferi","year":"2004","unstructured":"Tofferi JK, Jackson JL, O\u2019Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004;51(1):9\u201313.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"879_CR134","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.3899\/jrheum.110194","volume":"38","author":"H Moldofsky","year":"2011","unstructured":"Moldofsky H, et al. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study. J Rheumatol. 2011;38(12):2653\u201363.","journal-title":"J Rheumatol"},{"issue":"5","key":"879_CR135","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.mayocp.2016.02.002","volume":"91","author":"DL Goldenberg","year":"2016","unstructured":"Goldenberg DL, et al. Opioid use in fibromyalgia: a cautionary tale. Mayo Clin Proc. 2016;91(5):640\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"879_CR136","first-page":"CD012329","volume":"9","author":"H Gaskell","year":"2016","unstructured":"Gaskell H, et al. Oxycodone for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016;9(9):CD012329.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"879_CR137","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.2019.1347","volume":"321","author":"C Zeng","year":"2019","unstructured":"Zeng C, et al. Association of tramadol with all-cause mortality among patients with osteoarthritis. JAMA. 2019;321(10):969\u201382.","journal-title":"JAMA"},{"issue":"10","key":"879_CR138","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1093\/pm\/pnaa001","volume":"21","author":"K Bruun-Plesner","year":"2020","unstructured":"Bruun-Plesner K, et al. Low-dose naltrexone for the treatment of fibromyalgia: investigation of dose\u2013response relationships. Pain Med. 2020;21(10):2253\u201361.","journal-title":"Pain Med"},{"issue":"2","key":"879_CR139","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.37734","volume":"65","author":"J Younger","year":"2013","unstructured":"Younger J, et al. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013;65(2):529\u201338.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"879_CR140","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1526-4637.2009.00613.x","volume":"10","author":"J Younger","year":"2009","unstructured":"Younger J, Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med. 2009;10(4):663\u201372.","journal-title":"Pain Med"},{"issue":"10","key":"879_CR141","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1080\/1744666X.2019.1665997","volume":"15","author":"P Sarzi-Puttini","year":"2019","unstructured":"Sarzi-Puttini P, et al. Medical cannabis and cannabinoids in rheumatology: where are we now? Expert Rev Clin Immunol. 2019;15(10):1019\u201332.","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"879_CR142","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000492600","volume":"87","author":"D Baumeister","year":"2018","unstructured":"Baumeister D, et al. Plasma parameters of the endocannabinoid system are unaltered in fibromyalgia. Psychother Psychosom. 2018;87(6):377\u20139.","journal-title":"Psychother Psychosom"},{"issue":"8","key":"879_CR143","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/acr.21732","volume":"64","author":"PA Ste-Marie","year":"2012","unstructured":"Ste-Marie PA, et al. Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia. Arthritis Care Res (Hoboken). 2012;64(8):1202\u20138.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"4","key":"879_CR144","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","volume":"160","author":"T van de Donk","year":"2019","unstructured":"van de Donk T, et al. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. 2019;160(4):860\u20139.","journal-title":"Pain"},{"issue":"4","key":"879_CR145","doi-asserted-by":"publisher","first-page":"e18440","DOI":"10.1371\/journal.pone.0018440","volume":"6","author":"J Fiz","year":"2011","unstructured":"Fiz J, et al. Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLoS ONE. 2011;6(4):e18440.","journal-title":"PLoS ONE"},{"issue":"5","key":"879_CR146","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/RHU.0000000000000702","volume":"24","author":"G Habib","year":"2018","unstructured":"Habib G, Artul S. Medical cannabis for the treatment of fibromyalgia. J Clin Rheumatol. 2018;24(5):255\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"879_CR147","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/jcm8060807","volume":"8","author":"I Sagy","year":"2019","unstructured":"Sagy I, et al. Safety and efficacy of medical cannabis in fibromyalgia. J Clin Med. 2019;8(6):807.","journal-title":"J Clin Med"},{"key":"879_CR148","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.maturitas.2018.10.010","volume":"118","author":"O Beauchet","year":"2018","unstructured":"Beauchet O. Medical cannabis use in older patients: update on medical knowledge. Maturitas. 2018;118:56\u20139.","journal-title":"Maturitas"},{"issue":"3","key":"879_CR149","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.mcna.2020.01.004","volume":"104","author":"C Levy","year":"2020","unstructured":"Levy C, Galenbeck E, Magid K. Cannabis for symptom management in older adults. Med Clin N Am. 2020;104(3):471\u201389.","journal-title":"Med Clin N Am"},{"issue":"1","key":"879_CR150","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40266-018-0616-5","volume":"36","author":"A Minerbi","year":"2019","unstructured":"Minerbi A, H\u00e4user W, Fitzcharles MA. Medical cannabis for older patients. Drugs Aging. 2019;36(1):39\u201351.","journal-title":"Drugs Aging"},{"issue":"12","key":"879_CR151","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1016\/j.pain.2014.09.004","volume":"155","author":"B Olivan-Bl\u00e1zquez","year":"2014","unstructured":"Olivan-Bl\u00e1zquez B, et al. Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up. Pain. 2014;155(12):2517\u201325.","journal-title":"Pain"},{"issue":"2","key":"879_CR152","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/biomedicines5020015","volume":"5","author":"G Littlejohn","year":"2017","unstructured":"Littlejohn G, Guymer E. Modulation of NMDA receptor activity in fibromyalgia. Biomedicines. 2017;5(2):15.","journal-title":"Biomedicines."},{"issue":"8","key":"879_CR153","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/art.21191","volume":"52","author":"AJ Holman","year":"2005","unstructured":"Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 2005;52(8):2495\u2013505.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"879_CR154","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.neuropharm.2004.08.019","volume":"47","author":"Y Wu","year":"2004","unstructured":"Wu Y, et al. Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence. Neuropharmacology. 2004;47(8):1146\u201356.","journal-title":"Neuropharmacology"},{"issue":"8","key":"879_CR155","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/ejp.564","volume":"18","author":"S Perrot","year":"2014","unstructured":"Perrot S, Russell IJ. More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms. Eur J Pain. 2014;18(8):1067\u201380.","journal-title":"Eur J Pain"},{"issue":"6","key":"879_CR156","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/pm\/pnz251","volume":"21","author":"I Wilderman","year":"2020","unstructured":"Wilderman I, et al. Repeated intravenous lidocaine infusions for patients with fibromyalgia: higher doses of lidocaine have a stronger and longer-lasting effect on pain reduction. Pain Med. 2020;21(6):1230\u20139.","journal-title":"Pain Med"},{"issue":"3","key":"879_CR157","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1163\/156856900750232515","volume":"12","author":"G McCleane","year":"2000","unstructured":"McCleane G. Does intravenous lidocaine reduce fibromyalgia pain? A randomized, double-blind, placebo controlled cross-over study. Pain Clin. 2000;12(3):181\u20135.","journal-title":"Pain Clin."},{"issue":"1\u20132","key":"879_CR158","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pain.2009.05.020","volume":"145","author":"R Staud","year":"2009","unstructured":"Staud R, et al. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain. 2009;145(1\u20132):96\u2013104.","journal-title":"Pain"},{"issue":"1","key":"879_CR159","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejpain.2010.09.002","volume":"15","author":"G Affaitati","year":"2011","unstructured":"Affaitati G, et al. Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain. 2011;15(1):61\u20139.","journal-title":"Eur J Pain"},{"issue":"9","key":"879_CR160","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/0269215511399476","volume":"25","author":"AM Castro-Sanchez","year":"2011","unstructured":"Castro-Sanchez AM, et al. Effects of myofascial release techniques on pain, physical function, and postural stability in patients with fibromyalgia: a randomized controlled trial. Clin Rehabil. 2011;25(9):800\u201313.","journal-title":"Clin Rehabil"},{"issue":"4","key":"879_CR161","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1300\/J094v15n04_07","volume":"15","author":"GD Ko","year":"2007","unstructured":"Ko GD, et al. Effective pain palliation in fibromyalgia syndrome patients with botulinum toxin type-A: case series of 25. J Musculoskelet Pain. 2007;15(4):55\u201366.","journal-title":"J Musculoskelet Pain."},{"issue":"4","key":"879_CR162","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mds.870110425","volume":"11","author":"GW Paulson","year":"1996","unstructured":"Paulson GW, Gill W. Botulinum toxin is unsatisfactory therapy for fibromyalgia. Mov Disord. 1996;11(4):459.","journal-title":"Mov Disord"},{"issue":"1","key":"879_CR163","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40520-014-0238-7","volume":"27","author":"SA Jacobson","year":"2015","unstructured":"Jacobson SA, et al. Characterization of fibromyalgia symptoms in patients 55\u201395 years old: a longitudinal study showing symptom persistence with suboptimal treatment. Aging Clin Exp Res. 2015;27(1):75\u201382.","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"879_CR164","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10067-011-1870-7","volume":"31","author":"RP Campos","year":"2012","unstructured":"Campos RP, Vazquez MI. Health-related quality of life in women with fibromyalgia: clinical and psychological factors associated. Clin Rheumatol. 2012;31(2):347\u201355.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"879_CR165","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.1780400905","volume":"40","author":"F Wolfe","year":"1997","unstructured":"Wolfe F, et al. Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum. 1997;40(9):1571\u20139.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"879_CR166","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3899\/jrheum.110026","volume":"38","author":"B Walitt","year":"2011","unstructured":"Walitt B, et al. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol. 2011;38(10):2238\u201346.","journal-title":"J Rheumatol"},{"issue":"4","key":"879_CR167","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10880-011-9263-2","volume":"18","author":"MP Martinez","year":"2011","unstructured":"Martinez MP, et al. The relationship between the fear-avoidance model of pain and personality traits in fibromyalgia patients. J Clin Psychol Med Settings. 2011;18(4):380\u201391.","journal-title":"J Clin Psychol Med Settings"},{"issue":"2","key":"879_CR168","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/acr.20653","volume":"64","author":"CH Kim","year":"2012","unstructured":"Kim CH, et al. The association of body mass index with symptom severity and quality of life in patients with fibromyalgia. Arthritis Care Res (Hoboken). 2012;64(2):222\u20138.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"8","key":"879_CR169","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3899\/jrheum.141315","volume":"42","author":"DA Redelmeier","year":"2015","unstructured":"Redelmeier DA, et al. Fibromyalgia and the risk of a subsequent motor vehicle crash. J Rheumatol. 2015;42(8):1502\u201310.","journal-title":"J Rheumatol"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-021-00879-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T17:57:01Z","timestamp":1725386221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-021-00879-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":169,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1007\/s40266-021-00879-x","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]},"assertion":[{"value":"7 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was provided for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Amir Minerbi and Mary-Ann Fitzcharles have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Both authors participated in the writing of this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}